Yasmin, HasinaKhan, Md. Shohan2023-01-152023-01-1520222022-02ID: 18146030http://hdl.handle.net/10361/17720Cataloged from PDF version of thesis.Includes bibliographical references (pages 01-12).This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.Immunotherapy may hold promise as a treatment for coronavirus disease, the greatest epidemic this generation has seen, a disease that has wreaked havoc on the world's health and economic systems. We believe that using DC vaccine therapy as a treatment method for COVID-19 could be beneficial. Due to their immune-compromised status, cancer patients are among the most vulnerable people. In this review, the various approaches and conventional technologies employed to develop vaccines against COVID-19 will be compared with dendritic cell vaccines to show how dendritic cell vaccines can be a ray of hope for the world to be a healthy place again and also how it can boost up the overall vaccination process.46 Pagesen-USBrac University theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission.Dendritic cellVaccinesCOVID-19Immune-responseCytokinesImmunization.Dendritic Cells--immunology.Thesis